The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. - Wikidata - wikimedia - TriplyDB

The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer.

The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer.

http://www.wikidata.org/entity/Q40390461

about

RNA-binding IMPs promote cell adhesion and invadopodia formation.Lung cancer-initiating cells: a novel target for cancer therapy Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer Identification of uPAR-positive chemoresistant cells in small cell lung cancer Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147 Podoplanin associates with CD44 to promote directional cell migration Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression.Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.Cancerous stem cells: deviant stem cells with cancer-causing misbehavior.Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells.Proteome analysis of multidrug-resistant, breast cancer-derived microparticles.Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element.Carboxymethyl Hyaluronan-Stabilized Nanoparticles for Anticancer Drug Delivery.Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells.CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination P-glycoprotein Mediates Postoperative Peritoneal Adhesion Formation by Enhancing Phosphorylation of the Chloride Channel-3.HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma Identification of the Interaction between P-Glycoprotein and Anxa2 in Multidrug-resistant Human Breast Cancer Cells.Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells.Breast cancer stem cells, pathways and therapeutic perspectives 2011.Breast cancer stem cells: implications for therapy of breast cancer.Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells.Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.Liver stem cells and hepatocellular carcinoma.Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells

P2860

Q24542808-14073FE3-FCE5-4855-9DAA-645C03F00134 Q26824222-F9A02734-4D0F-4DBB-AB22-5BC299426130 Q27021261-7E12DE19-1F93-411F-ACD4-CED0B03D40B4 Q28469143-8456C69C-1B90-4B90-A8B0-B6579836A0AA Q28477846-03D0CB59-0D68-48C1-9C4D-FC285A1271B7 Q28482047-BD92BB13-DC93-470B-ABA2-5DD1C45ABE5D Q30090217-3B5A4FC7-9C96-44D8-9627-414FD20FAC90 Q30357883-3FDF7970-D61D-4603-AC09-80A8A25E4E5B Q30414688-3ADD861A-5A3F-4FFA-B44D-FAEC52018BCB Q30454570-5179EED5-C3F6-4ECB-871C-8AA09B0DB5E3 Q30454572-24379D7F-7451-4CC0-963C-74C991C539E3 Q30478184-E56BD708-DBB4-4D85-88B9-E754697E68E8 Q33482138-A413F4AA-6983-49AD-A3C3-03C75D0B3537 Q33688875-EC0AA8E4-8C7D-4524-BEC0-B37D47AE02FE Q33958763-82201012-AECA-4F03-9704-3899929A09C9 Q33999466-A3A0CC46-4138-484C-83C4-3324598E4CA4 Q34048932-3B197E08-F91C-478D-B8FD-502AFAAA5788 Q34080036-937F2048-0BC7-4AC3-911D-2A2F127AD330 Q35017209-77A9AF04-7230-4FB3-99EA-83F76FF778F1 Q35089472-6F54B8A6-07E8-4335-AE20-4520CB76242C Q35510360-EE1683D4-1765-40F6-98B3-F3EA0DAF28D3 Q35746515-F62F537D-4C5B-4939-A5DB-E8F43333D048 Q36003640-D49B7C47-0DFD-4395-8D90-B1EF7BDFE43A Q36089319-951C9B1C-EC54-4DDC-A120-58DDCD5DEC50 Q36247462-084191D1-7EE3-4A62-94D1-9DE3D5319D46 Q36413446-9131E456-F5AD-420A-949D-AA113B4D37EF Q36510853-2A807090-36DD-4F6A-A638-E80448A3AD53 Q36544516-76850C9D-CF0A-4BA7-845A-15731852E7C3 Q36719279-C374AB7C-5DE5-4A80-8F6D-EC891AC75F69 Q36805567-89E093B0-87D7-4E18-A2D0-C28C244CF723 Q36814383-84143489-EBCF-4D59-92F8-C1A51AB26047 Q36839505-168A752F-4218-4CFB-98DE-2F6B575A70FB Q36946326-12AA675F-3DDE-478B-A504-E6EA30CAA29F Q36955061-D042F0D0-2DD8-45B0-A71F-018A953E3FBF Q36976346-5A6B3B4F-7BB5-449E-99CD-F2A9309E6722 Q37012579-6D9DC4BB-CE7A-433B-BE17-6E3C917CB43C Q37092712-35871705-56EA-4344-A136-679722AA6926 Q37356199-EFA4BE98-3D2E-433E-A88B-3E1F6E83A1AF Q37358938-5C4BDA11-7538-4DBD-82C2-A09B566E64F0 Q37377476-7BEE7194-09A8-43CD-BDD2-518AF5C082A5

P2860

The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer.

http://www.wikidata.org/entity/Q40390461

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

The CD44 receptor interacts wi ...... ration and invasion in cancer.

@en

type

label

The CD44 receptor interacts wi ...... ration and invasion in cancer.

@en

prefLabel

The CD44 receptor interacts wi ...... ration and invasion in cancer.

@en

P1433

Q40390461-87C6ABCF-97E6-415F-968E-DD488A839E4C

P1476

Q40390461-D2327FA9-0A3A-4B74-BB89-7B8FADEDC9A1

P2093

Q40390461-03CC43B9-246C-45EE-B908-CE5A66B4B0F5

Q40390461-18D365F4-4BF9-4461-841D-4EF7C87CC6A4

Q40390461-1AD3D2C7-7076-47EB-8009-C502F7E9FC3B

Q40390461-450BFAC9-962B-4FEF-8F17-0EC6C2D08A47

Q40390461-4AC363B9-8879-4BAA-B5F5-05DB745577B0

Q40390461-4E5663E8-653F-40F4-A6B4-CF6B31F9A579

Q40390461-99EF8CB8-FD37-413F-BE28-3B14DD1AD61E

Q40390461-C2443CC4-691E-4AAF-9C45-B88D97D51F44

Q40390461-C82E669A-997D-458D-81B5-7AC59050DD7C

Q40390461-CF2876CB-D2A9-47A8-9981-5390FA88EE75

P304

Q40390461-5090822D-D08E-47AD-8E83-95632912F8E8

P31

Q40390461-34447B47-AC32-4206-93FD-9E991292B0B4

P356

Q40390461-7F20BB0E-8A06-47FB-AC52-1A7C6131E0C8

P407

Q40390461-1516A64C-25B0-46A4-B0DF-45DEDFF1546D

P433

Q40390461-D32340FF-9D00-40CA-9A57-E45A4CA70AFE

P478

Q40390461-9AC6A088-F8A9-402A-87E6-05CCAD7D7F7C

P577

Q40390461-57FBA88A-198C-43AE-8F1D-A7493724331F

P5875

Q40390461-F165EB39-E20C-4485-8FC6-8B425ED2CB20

P698

Q40390461-BC8BB953-9ABB-4EFE-BA54-3F23826A0768

P356

0008-5472.CAN-04-3478

P1433

Cancer Research

P1476

The CD44 receptor interacts wi ...... ration and invasion in cancer.

@en

P2093

Giuseppa N Saglimbeni

http://www.w3.org/2001/XMLSchema#string

Jinming Yang

http://www.w3.org/2001/XMLSchema#string

Karl E Miletti-González

http://www.w3.org/2001/XMLSchema#string

Kevin Apolito

http://www.w3.org/2001/XMLSchema#string

Lorna Rodríguez-Rodríguez

http://www.w3.org/2001/XMLSchema#string

Neelakandan Muthukumaran

http://www.w3.org/2001/XMLSchema#string

Shiling Chen

http://www.w3.org/2001/XMLSchema#string

Weichung J Shih

http://www.w3.org/2001/XMLSchema#string

William N Hait

http://www.w3.org/2001/XMLSchema#string

Xiaohua Wu

http://www.w3.org/2001/XMLSchema#string

P304

6660-6667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-04-3478

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7685550

http://www.w3.org/2001/XMLSchema#string

P698

16061646

http://www.w3.org/2001/XMLSchema#string